These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 1417929)

  • 1. Studies of in vivo iron mobilization by chelators in the ferrocene-loaded rat.
    Florence A; Ward RJ; Peters TJ; Crichton RR
    Biochem Pharmacol; 1992 Sep; 44(6):1023-7. PubMed ID: 1417929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antioxidant and free radical scavenging activities of the iron chelators pyoverdin and hydroxypyrid-4-ones in iron-loaded hepatocyte cultures: comparison of their mechanism of protection with that of desferrioxamine.
    Morel I; Cillard J; Lescoat G; Sergent O; Pasdeloup N; Ocaktan AZ; Abdallah MA; Brissot P; Cillard P
    Free Radic Biol Med; 1992 Nov; 13(5):499-508. PubMed ID: 1334028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subcellular distribution of desferrioxamine and hydroxypyridin-4-one chelators in K562 cells affects chelation of intracellular iron pools.
    Hoyes KP; Porter JB
    Br J Haematol; 1993 Oct; 85(2):393-400. PubMed ID: 8280612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iron chelation studies using desferrioxamine and the potential oral chelator, 1,2-dimethyl-3-hydroxypyrid-4-one, in normal and iron loaded rats.
    Kontoghiorghes GJ; Sheppard L; Hoffbrand AV; Charalambous J; Tikerpae J; Pippard MJ
    J Clin Pathol; 1987 Apr; 40(4):404-8. PubMed ID: 3584483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical and biophysical investigations of the ferrocene-iron-loaded rat. An animal model of primary haemochromatosis.
    Ward RJ; Florence AL; Baldwin D; Abiaka C; Roland F; Ramsey MH; Dickson DP; Peters TJ; Crichton RR
    Eur J Biochem; 1991 Dec; 202(2):405-10. PubMed ID: 1761043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ability of the orally effective iron chelators dimethyl- and diethyl-hydroxypyrid-4-one and of deferoxamine to restore sarcolemmal thiolic enzyme activity in iron-loaded heart cells.
    Link G; Pinson A; Hershko C
    Blood; 1994 May; 83(9):2692-7. PubMed ID: 8167347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of iron toxicity in rat and human hepatocyte cultures by the hydroxypyridin-4-ones CP20 and CP94.
    Chenoufi N; Hubert N; Loréal O; Morel I; Pasdeloup N; Cillard J; Brissot P; Lescoat G
    J Hepatol; 1995 Aug; 23(2):166-73. PubMed ID: 7499788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of the iron-clearing properties of 1,2-dimethyl-3-hydroxypyrid-4-one, 1,2-diethyl-3-hydroxypyrid-4-one, and deferoxamine.
    Bergeron RJ; Streiff RR; Wiegand J; Luchetta G; Creary EA; Peter HH
    Blood; 1992 Apr; 79(7):1882-90. PubMed ID: 1558978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An animal model of iron overload and its application to study hepatic ferritin iron mobilization by chelators.
    Longueville A; Crichton RR
    Biochem Pharmacol; 1986 Nov; 35(21):3669-78. PubMed ID: 3778498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of chelators on iron uptake and release by the brain in the rat.
    Crowe A; Morgan EH
    Neurochem Res; 1994 Jan; 19(1):71-6. PubMed ID: 8139766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the "iron shuttle" hypothesis in chelation therapy: effects of combined deferoxamine and deferiprone treatment in hypertransfused rats with labeled iron stores and in iron-loaded rat heart cells in culture.
    Link G; Konijn AM; Breuer W; Cabantchik ZI; Hershko C
    J Lab Clin Med; 2001 Aug; 138(2):130-8. PubMed ID: 11477380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative study of the protective effect between deferoxamine and deferiprone on chronic iron overload induced cardiotoxicity in rats.
    Emara AM; El Kelany RS; Moustafa KA
    Hum Exp Toxicol; 2006 Jul; 25(7):375-85. PubMed ID: 16898166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chelation of aluminium by combining DFO and L1 in rats.
    Blanusa M; Prester L; Varnai VM; Pavlović D; Kostial K; Jones MM; Singh PK
    Toxicology; 2000 Jul; 147(3):151-6. PubMed ID: 10924797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism of iron from (3,5,5-trimethylhexanoyl)ferrocene in rats. A dietary model for severe iron overload.
    Nielsen P; Heinrich HC
    Biochem Pharmacol; 1993 Jan; 45(2):385-91. PubMed ID: 8435091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of desferrithiocin and its derivatives on peripheral iron and striatal dopamine and 5-hydroxytryptamine metabolism in the ferrocene-loaded rat.
    Dexter DT; Ward RJ; Florence A; Jenner P; Crichton RR
    Biochem Pharmacol; 1999 Jul; 58(1):151-5. PubMed ID: 10403528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EPR study of antioxidant activity of the iron chelators pyoverdin and hydroxypyrid-4-one in iron-loaded hepatocyte culture: comparison with that of desferrioxamine.
    Morel I; Sergent O; Cogrel P; Lescoat G; Pasdeloup N; Brissot P; Cillard P; Cillard J
    Free Radic Biol Med; 1995 Feb; 18(2):303-10. PubMed ID: 7744315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain iron in the ferrocene-loaded rat: its chelation and influence on dopamine metabolism.
    Ward RJ; Dexter D; Florence A; Aouad F; Hider R; Jenner P; Crichton RR
    Biochem Pharmacol; 1995 Jun; 49(12):1821-6. PubMed ID: 7598744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative efficacy and toxicity of desferrioxamine, deferiprone and other iron and aluminium chelating drugs.
    Kontoghiorghes GJ
    Toxicol Lett; 1995 Oct; 80(1-3):1-18. PubMed ID: 7482575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selection of a new generation of orally active alpha-ketohydroxypyridine iron chelators intended for use in the treatment of iron overload.
    Kontoghiorghes GJ; Barr J; Nortey P; Sheppard L
    Am J Hematol; 1993 Apr; 42(4):340-9. PubMed ID: 8493983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo and in vitro effects of 3-hydroxypyridin-4-one chelators on murine hemopoiesis.
    Hoyes KP; Jones HM; Abeysinghe RD; Hider RC; Porter JB
    Exp Hematol; 1993 Jan; 21(1):86-92. PubMed ID: 8417963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.